 |
| |
| Oct-01-19 | Resumed |
Craig Hallum |
Buy |
$48 |
|
| May-09-19 | Upgrade |
H.C. Wainwright |
Neutral → Buy |
$30 → $43 |
|
| Feb-15-19 | Initiated |
Jefferies |
Buy |
$35 |
|
| Oct-23-18 | Resumed |
Raymond James |
Strong Buy |
$30 |
|
| Sep-18-18 | Reiterated |
H.C. Wainwright |
Neutral |
$17 → $22 |
|
| Nov-27-17 | Initiated |
H.C. Wainwright |
Buy |
$12 |
|
| Jun-14-16 | Reiterated |
Mizuho |
Buy |
$12 → $8 |
|
| Sep-29-15 | Downgrade |
Raymond James |
Outperform → Mkt Perform |
|
|
| Sep-25-15 | Initiated |
Craig Hallum |
Buy |
|
|
| Mar-18-15 | Reiterated |
Mizuho |
Buy |
$15 → $12 |
|
|
|
| Feb-20-20 12:31PM | CareDx (CDNA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks |
| Feb-19-20 11:18AM | The Zacks Analyst Blog Highlights: Smith Micro Software, Accuray, Vista Outdoor, Synaptics and CareDx Zacks |
| Feb-18-20 08:47AM | Trump Mulling Tax Cuts to Incentivize Stock Buying? 6 Picks Zacks |
| Feb-13-20 07:00AM | CareDx to Report Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020 GlobeNewswire |
| Feb-11-20 07:00AM | CareDxs Patent Rights Upheld By Delaware Court GlobeNewswire |
| Feb-07-20 12:00PM | CareDx (CDNA) Upgraded to Strong Buy: Here's Why Zacks -5.07% |
| Feb-06-20 09:16AM | US Service Sector Accelerates in January: 5 Stocks to Buy Zacks |
| Feb-04-20 08:15AM | The Zacks Analyst Blog Highlights: Calavo Growers, Darling Ingredients, The Simply Good Foods Company, KalVista Pharmaceuticals and CareDx Zacks |
| 07:00AM | CareDx Launches AiTraC Conference GlobeNewswire |
| Feb-03-20 11:54AM | 5 Defensive Stocks to Counter Coronavirus Scare Zacks |
| 06:55AM | Super Bowl Results Show Stock Gains in February: 5 Picks Zacks |
| Jan-22-20 04:44PM | Teladoc (TDOC) Hits 52-Week High: Will Momentum Sustain? Zacks |
| 06:15AM | When Will CareDx, Inc (NASDAQ:CDNA) Breakeven? Simply Wall St. |
| Jan-13-20 07:00AM | CareDx Reports Preliminary Fourth Quarter and Full Year 2019 Results GlobeNewswire +13.33% |
| Jan-10-20 07:00AM | CareDxs AlloSeq cfDNA Awarded CE Mark Approval GlobeNewswire |
| Jan-09-20 07:00AM | CareDx Leadership at ASTS Meeting GlobeNewswire |
| Jan-08-20 07:00AM | CareDx's False Advertising Complaint Upheld By Court GlobeNewswire |
| Dec-24-19 07:00AM | CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire |
| Dec-23-19 02:38PM | CareDx Supports Bipartisan Legislation to Protect Kidney Transplant Patients GlobeNewswire |
| Dec-17-19 05:28AM | Should You Be Concerned About CareDx, Inc's (NASDAQ:CDNA) Historical Volatility? Simply Wall St. |
| Dec-07-19 12:26PM | Is CareDx, Inc. (CDNA) A Good Stock To Buy? Insider Monkey |
| Nov-19-19 07:00AM | CareDx to Participate in Upcoming Investor Conferences GlobeNewswire |
| Nov-11-19 08:36AM | Did The Underlying Business Drive CareDx's (NASDAQ:CDNA) Lovely 417% Share Price Gain? Simply Wall St. |
| Nov-06-19 12:19PM | Edited Transcript of CDNA earnings conference call or presentation 31-Oct-19 8:30pm GMT Thomson Reuters StreetEvents |
| 07:00AM | CareDx at ASN Kidney Week GlobeNewswire |
| Nov-04-19 07:00AM | CareDx Advances Patient Care with AlloSure 3.0 GlobeNewswire -10.26% |
| Nov-01-19 09:00AM | All You Need to Know About CareDx (CDNA) Rating Upgrade to Strong Buy Zacks -11.90% |
| 07:38AM | The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance Benzinga |
| Oct-31-19 04:05PM | CareDx Reports Third Quarter 2019 Results GlobeNewswire |
| Oct-26-19 12:48PM | Were Hedge Funds Right About Flocking Into CareDx, Inc. (CDNA)? Insider Monkey |
| Oct-18-19 10:09AM | Top Ranked Momentum Stocks to Buy for October 18th Zacks |
| Oct-17-19 08:00AM | CareDx to Announce Third Quarter 2019 Financial Results on October 31st, 2019 GlobeNewswire |
| Oct-12-19 09:25AM | We're Excited To See How CareDx (NASDAQ:CDNA) Uses Its Cash Hoard To Grow Simply Wall St. |
| Oct-07-19 10:20AM | CareDx, Inc (CDNA) Shares March Higher, Can It Continue? Zacks |
| Sep-26-19 09:25AM | CareDx Files Patent Infringement Lawsuit Against Eurofins Viracor GlobeNewswire |
| Sep-24-19 08:00AM | CareDx Adds HistoMap To Testing Portfolio GlobeNewswire -5.60% |
| Sep-23-19 08:00AM | CareDxs KidneyCare iBox Technology Clinically Validated in BMJ Publication GlobeNewswire |
| Sep-20-19 08:00AM | CareDx Launches AlloSeq® Tx 17 at ASHI/BANFF Meeting GlobeNewswire |
| Sep-18-19 08:00AM | First Patient Enrolled in Landmark CareDx OKRA Registry GlobeNewswire |
| Sep-17-19 08:00AM | CareDx to Participate in the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire |
| Sep-12-19 08:00AM | CareDx launches AlloSeq® cfDNA at ESOT 2019 GlobeNewswire +7.44% |
| 07:41AM | Who Has Been Selling CareDx, Inc (NASDAQ:CDNA) Shares? Simply Wall St. |
| Sep-11-19 04:01PM | CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire |
| Aug-28-19 08:00AM | CareDx Acquires XynManagement GlobeNewswire |
| Aug-27-19 08:00AM | Chris Cournoyer Joins CareDx Board of Directors GlobeNewswire |
| Aug-22-19 09:48AM | AlloSure for Heart Transplant Patients Receives CMS Draft Coverage GlobeNewswire |
| Aug-21-19 08:00AM | Fear of Rejection is Transplant Patients Top Concern GlobeNewswire |
| Aug-09-19 01:45PM | CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Reminds Investors of Its Investigation of CareDx Inc.- CDNA ACCESSWIRE -8.39% |
| Aug-08-19 07:16PM | Caredx Inc (CDNA) CEO Peter Maag Sold $1.4 million of Shares GuruFocus.com |
| Aug-05-19 09:30PM | Bragar Eagel & Squire, P.C. is Investigating CareDx, Inc. (NASDAQ: CDNA) on Behalf of Stockholders and Encourages CareDx Investors to Contact the Firm GlobeNewswire -12.40% |
| 11:40AM | Edited Transcript of CDNA earnings conference call or presentation 1-Aug-19 8:30pm GMT Thomson Reuters StreetEvents |
| 06:06AM | Is CareDx, Inc's (NASDAQ:CDNA) CEO Salary Justified? Simply Wall St. |
| Aug-03-19 09:15AM | INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. Business Wire |
| Aug-02-19 01:31AM | CareDx, Inc (CDNA) Q2 2019 Earnings Call Transcript Motley Fool |
| Aug-01-19 04:01PM | CareDx Reports Second Quarter 2019 Results GlobeNewswire |
| Jul-30-19 08:10PM | CDNA INVESTIGATION REMINDER: Hagens Berman Reminds CareDx (CDNA) Investors to Investigation of Possible Disclosure Violations ACCESSWIRE |
| 12:32PM | CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Reminds Investors of Its Investigation of CareDx Inc. CDNA GlobeNewswire |
| 11:44AM | CAREDX INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In CareDx, Inc. To Contact The Firm GlobeNewswire |
| Jul-26-19 05:25PM | Lifshitz & Miller LLP Announces Investigation of Amneal Pharmaceuticals, Inc., CareDx, Inc., Casa Systems, Inc., India Globalization Capital, Inc., Just Energy Group Inc., LegacyTexas Financial Group, Inc., Maxar Technologies Inc., and Unum Group PR Newswire |
| Jul-25-19 10:34AM | CareDx (CDNA) Reports Next Week: Wall Street Expects Earnings Growth Zacks -5.12% |
| Jul-24-19 07:07PM | CAREDX INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In CareDx, Inc. To Contact The Firm PR Newswire |
| Jul-23-19 12:29PM | CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Reminds Investors of Its Investigation of CareDx Inc. CDNA GlobeNewswire |
| Jul-22-19 09:00PM | Glancy Prongay & Murray LLP Continues Investigation on Behalf of CareDx, Inc. Investors (CDNA) Business Wire |
| 06:22PM | INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of CareDx, Inc. Investors (CDNA) Business Wire |
| Jul-17-19 09:30PM | Bragar Eagel & Squire, P.C. Is Investigating Hibbett Sports, Pintec Technology, CareDX, and Ideanomics on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire |
| 03:18PM | CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Announces Investigation of CareDx Inc.-- CDNA PR Newswire |
| Jul-16-19 08:03PM | CDNA INVESTIGATION ALERT: Hagens Berman Alerts CareDx (CDNA) Investors to Investigation of Possible Disclosure Violations PR Newswire -12.91% |
| 04:51PM | Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) Business Wire |
| 04:09PM | Here's Why CareDx Stock Is Sliding Today Motley Fool |
| 01:51PM | INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) Business Wire |
| Jul-11-19 08:00AM | CareDx Applauds White House Efforts to Reform Americas Kidney Health System GlobeNewswire |
| 04:50AM | CareDx Looks Like It Can Continue Its Impressive Rally, So Go Long TheStreet.com |
| Jul-10-19 05:32PM | Trump's Kidney Disease Executive Order May Boost This Health Stock, Tank Others Zacks |
| Jul-09-19 10:00AM | What You Must Know About CareDx, Inc's (NASDAQ:CDNA) Beta Value Simply Wall St. +9.01% |
| Jul-02-19 08:00AM | Grace Colón succeeds Amy Abernethy on the CareDx Board GlobeNewswire |
| Jun-27-19 08:00AM | CareDx Supports Momentum in Medicare Immunosuppressive Medication Legislation GlobeNewswire |
| Jun-26-19 08:00AM | US Patent Office Issues New Transplant Patent to CareDx GlobeNewswire |
| Jun-19-19 06:51PM | Hedge Funds Have Never Been This Bullish On CareDx, Inc. (CDNA) Insider Monkey |
| Jun-10-19 08:00AM | CareDx to Participate in Upcoming Conferences GlobeNewswire |
| Jun-03-19 01:55PM | Is CareDx, Inc (NASDAQ:CDNA) Trading At A 41% Discount? Simply Wall St. |
| May-29-19 08:00AM | CareDx Announces KidneyCare and Showcases Leadership in Transplantation at ATC GlobeNewswire |
| May-22-19 08:36AM | CareDx to Participate in Upcoming Conferences GlobeNewswire |
| May-16-19 07:01PM | Edited Transcript of CDNA earnings conference call or presentation 8-May-19 8:30pm GMT Thomson Reuters StreetEvents |
| May-14-19 08:33AM | CareDx applauds HHS Report on Cost Savings of Lifetime Immunosuppressive Drug Coverage for Transplant Patients GlobeNewswire |
| May-09-19 12:14PM | Here's Why CareDx Stock Is Rising Today Motley Fool +12.86% |
| May-08-19 09:48PM | CareDx, Inc (CDNA) Q1 2019 Earnings Call Transcript Motley Fool |
| 06:45PM | CareDx (CDNA) Q1 Earnings and Revenues Top Estimates Zacks |
| 05:39PM | CareDx: 1Q Earnings Snapshot Associated Press |
| 04:01PM | CareDx Reports First Quarter 2019 Results GlobeNewswire |
| May-07-19 09:00AM | CareDxs AlloSeq cfDNA and QTYPE Solutions Featured at EFI 2019 GlobeNewswire -5.95% |
| May-06-19 07:32AM | The CareDx (NASDAQ:CDNA) Share Price Is Up 580% And Shareholders Are Delighted Simply Wall St. |
| May-03-19 09:25AM | Hedge Funds Have Never Been This Bullish On CareDx, Inc. (CDNA) Insider Monkey +5.92% |
| 08:00AM | AlloMap In-Network with Anthem Blue Cross GlobeNewswire |
| May-02-19 08:00AM | CareDx Adds iBox Technology, Next Step Towards Artificial Intelligence in Transplant Care GlobeNewswire |
| May-01-19 10:33AM | CareDx (CDNA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks |
| Apr-25-19 04:01PM | CareDx Agrees to Acquire OTTR Complete Transplant Management GlobeNewswire |
| Apr-23-19 08:00AM | CareDx to Announce First Quarter 2019 Financial Results on May 8th, 2019 GlobeNewswire |
| Apr-10-19 12:08PM | Breakeven On The Horizon For CareDx, Inc (NASDAQ:CDNA) Simply Wall St. |
| 11:15AM | CareDx Accuses Natera of False Advertising Claims That Mislead Medical Personnel and Transplant Patients GlobeNewswire |
| Apr-03-19 08:00AM | Cutting-Edge HeartCare and AlloMap Solutions Featured at ISHLT 2019 GlobeNewswire |
|
|
|
|
| CareDx, Inc., a transplant diagnostics company, together with its subsidiaries, focuses on the discovery, development, and commercialization of diagnostic solutions for transplant patients worldwide. The company develops and provides a diagnostic surveillance testing solution for heart and kidney transplant recipients. It offers AlloMap, a heart transplant molecular test; and AlloSure, a donor-derived cell-free DNA test initially used for kidney transplant patients. The company also develops, manufactures, markets, and sells products that increase the chance of successful transplants by facilitating a match between a donor and a recipient of stem cells and organs. It sells Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence-specific primer technology; Olerup SBT, a product range for sequence-based typing of HLA alleles; QTYPE that enables speed and precision in HLA typing at a low to intermediate resolution for samples that require a fast turn-around-time and uses real-time polymerase chain reaction methodology; and TruSight HLA, a high resolution solution that uses next generation sequencing methodology. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina for the development, commercialization, and distribution of next generation sequencing product line for use in transplantation diagnostic testing. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in Brisbane, California. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Maag Peter | Chief Executive Officer | Feb 18 | Sale | 26.62 | 10,000 | 266,201 | 451,909 | Feb 19 07:25 PM | | King Sasha | Chief Commercial Officer | Feb 14 | Sale | 26.01 | 7,390 | 192,221 | 48,502 | Feb 14 09:15 PM | | Maag Peter | Chief Executive Officer | Jan 15 | Sale | 23.13 | 10,000 | 231,300 | 429,814 | Jan 16 08:16 PM | | King Sasha | Chief Commercial Officer | Dec 09 | Sale | 21.97 | 2,126 | 46,708 | 48,709 | Dec 10 06:28 PM | | HAGSTROM WILLIAM A | Director | Dec 03 | Sale | 20.06 | 12,500 | 250,761 | 15,385 | Dec 05 08:22 PM | | Maag Peter | Chief Executive Officer | Aug 06 | Sale | 28.84 | 50,000 | 1,441,834 | 339,814 | Aug 08 04:10 PM | | Cohen Fred E | Director | Jul 11 | Option Exercise | 6.96 | 15,765 | 109,672 | 71,279 | Jul 15 04:27 PM | | Yee James P | Chief Medical Officer | Jul 01 | Option Exercise | 2.30 | 19,875 | 45,713 | 62,045 | Jul 01 09:24 PM | | King Sasha | Chief Commercial Officer | Jul 01 | Option Exercise | 1.00 | 250 | 250 | 57,877 | Jul 01 09:26 PM | | King Sasha | Chief Commercial Officer | Jul 01 | Sale | 35.74 | 9,542 | 341,045 | 48,335 | Jul 01 09:26 PM | | Yee James P | Chief Medical Officer | Jul 01 | Sale | 35.65 | 20,000 | 712,936 | 42,045 | Jul 01 09:24 PM | | King Sasha | Chief Commercial Officer | Jun 20 | Option Exercise | 10.49 | 16,195 | 169,816 | 88,467 | Jun 21 05:08 PM | | Bell Michael Brian | Chief Financial Officer | Jun 20 | Option Exercise | 10.99 | 14,702 | 161,594 | 85,602 | Jun 21 05:07 PM | | Bell Michael Brian | Chief Financial Officer | Jun 20 | Sale | 38.81 | 14,702 | 570,601 | 70,900 | Jun 21 05:07 PM | | King Sasha | Chief Commercial Officer | Jun 20 | Sale | 38.38 | 30,840 | 1,183,513 | 57,627 | Jun 21 05:08 PM | | Yee James P | Chief Medical Officer | Jun 17 | Option Exercise | 6.49 | 20,000 | 129,800 | 62,170 | Jun 18 07:02 PM | | Yee James P | Chief Medical Officer | Jun 17 | Sale | 37.54 | 20,000 | 750,876 | 42,170 | Jun 18 07:02 PM | | HAGSTROM WILLIAM A | Director | Jun 04 | Sale | 32.35 | 15,000 | 485,250 | 25,272 | Jun 04 09:35 PM | | Bell Michael Brian | Chief Financial Officer | May 20 | Option Exercise | 3.91 | 2,202 | 8,599 | 79,299 | May 22 06:05 AM | | Bell Michael Brian | Chief Financial Officer | May 20 | Sale | 32.10 | 2,202 | 70,694 | 77,097 | May 22 06:05 AM | | Maag Peter | Chief Executive Officer | May 13 | Sale | 31.11 | 80,000 | 2,488,496 | 408,406 | May 13 09:29 PM | | Bell Michael Brian | Chief Financial Officer | May 09 | Option Exercise | 3.90 | 2,201 | 8,593 | 91,991 | May 13 04:21 PM | | Bell Michael Brian | Chief Financial Officer | May 09 | Sale | 32.42 | 14,894 | 482,884 | 77,097 | May 13 04:21 PM | | King Sasha | Chief Commercial Officer | May 03 | Option Exercise | 6.04 | 1,250 | 7,546 | 77,844 | May 03 08:58 PM | | King Sasha | Chief Commercial Officer | May 03 | Sale | 29.50 | 1,250 | 36,875 | 76,594 | May 03 08:58 PM | | Maag Peter | See Remarks | Apr 17 | Option Exercise | 2.76 | 50,000 | 137,854 | 488,406 | Apr 18 07:52 PM | | King Sasha | Chief Commercial Officer | Apr 12 | Option Exercise | 5.11 | 12,707 | 64,920 | 86,594 | Apr 12 07:48 PM | | King Sasha | Chief Commercial Officer | Apr 12 | Sale | 29.81 | 10,000 | 298,064 | 76,594 | Apr 12 07:48 PM | | Maag Peter | See Remarks | Apr 12 | Sale | 29.11 | 100,000 | 2,910,530 | 438,406 | Apr 12 07:48 PM | | Maag Peter | See Remarks | Apr 09 | Option Exercise | 5.83 | 80,000 | 466,587 | 538,406 | Apr 09 09:43 PM | | Goldberg Michael | Director | Mar 14 | Sale | 37.36 | 50,000 | 1,867,825 | 84,740 | Mar 14 09:25 PM | | Yee James P | Chief Medical Officer | Mar 12 | Sale | 35.18 | 7,598 | 267,282 | 43,409 | Mar 12 09:09 PM | | Maag Peter | See Remarks | Mar 11 | Sale | 34.23 | 50,000 | 1,711,280 | 458,406 | Mar 11 09:15 PM | | Bell Michael Brian | Chief Financial Officer | Mar 01 | Sale | 31.36 | 13,000 | 407,742 | 77,290 | Mar 05 06:56 PM |
|
|
|
|
|
|
